Cancer Chemotherapy and Pharmacology View Homepage


Ontology type: schema:Periodical     


Journal Info

START YEAR

1978

PUBLISHER

Springer Berlin Heidelberg

LANGUAGE

en

HOMEPAGE

https://link.springer.com/journal/280

Recent publications latest 20 shown

  • 2022-05-04 Dose-dependent bioavailability, absorption-rate limited elimination, and tissue distribution of the ATR inhibitor BAY-1895344 (elimusertib) in mice
  • 2022-04-25 Comparison of docetaxel pharmacokinetics between castration-resistant and hormone-sensitive metastatic prostate cancer patients
  • 2022-04-23 An evaluation of the interaction of pixantrone with formaldehyde-releasing drugs in cancer cells
  • 2022-04-20 Effectiveness and safety of sorafenib for renal cell, hepatocellular and thyroid carcinoma: pooled analysis in patients with renal impairment
  • 2022-04-19 Feasibility of therapeutic drug monitoring of sunitinib and its implications on response and toxicity in patients with metastatic renal cell cancer
  • 2022-04-18 Elimination of tucatinib, a small molecule kinase inhibitor of HER2, is primarily governed by CYP2C8 enantioselective oxidation of gem-dimethyl
  • 2022-04-18 A phase 1 and pharmacodynamic study of chronically-dosed, single-agent veliparib (ABT-888) in patients with BRCA1- or BRCA2-mutated cancer or platinum-refractory ovarian or triple-negative breast cancer
  • 2022-04-15 Is age just a number? A population pharmacokinetic study of gemcitabine
  • 2022-04-15 Assessment of cytochrome P450 3A4-mediated drug–drug interactions for ipatasertib using a fit-for-purpose physiologically based pharmacokinetic model
  • 2022-04-13 An effective AKT inhibitor-PARP inhibitor combination therapy for recurrent ovarian cancer
  • 2022-04-10 Population pharmacokinetics of rucaparib in patients with advanced ovarian cancer or other solid tumors
  • 2022-04-06 Population pharmacokinetic analysis of tepotinib, an oral MET kinase inhibitor, including data from the VISION study
  • 2022-04-05 Editorial Expression of Concern for: Induction of apoptosis by [6]-gingerol associated with the modulation of p53 and involvement of mitochondrial signaling pathway in B[a]P-induced mouse skin tumorigenesis
  • 2022-04-02 Efficacy and safety exposure–response relationships of apalutamide in patients with metastatic castration-sensitive prostate cancer: results from the phase 3 TITAN study
  • 2022-04-01 Lurbinectedin-induced thrombocytopenia: the role of body surface area
  • 2022-03-30 Pharmacokinetics of metronomic temozolomide in cerebrospinal fluid of children with malignant central nervous system tumors
  • 2022-03-25 Anti-drug antibodies in the current management of cancer
  • 2022-03-23 A phase I pharmacokinetic study of copanlisib in Chinese patients with relapsed indolent non-Hodgkin lymphoma
  • 2022-03-22 Relationship between achievement of major molecular response or deep molecular response and nilotinib plasma concentration in patients with chronic myeloid leukemia receiving first-line nilotinib therapy
  • 2022-03-21 ATF4-mediated microRNA-145/HDAC4/p53 axis affects resistance of colorectal cancer cells to 5-fluorouracil by regulating autophagy
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "contentRating": [
          {
            "author": "snip", 
            "ratingValue": "0.9259999990463257", 
            "type": "Rating"
          }, 
          {
            "author": "sjr", 
            "ratingValue": "1.1119999885559082", 
            "type": "Rating"
          }
        ], 
        "description": "

    Cancer Chemotherapy and Pharmacology addresses a wide range of pharmacologic and oncologic concerns on both experimental and clinical levels. The primary focus of this rapid publication medium is on new anticancer agents, their experimental screening, preclinical toxicology and pharmacology, single and combined drug administration modalities, and clinical phase I, II and III trials.

    The journal publishes results recorded in the following areas: clinical toxicology, pharmacokinetics, pharmacodynamics, drug interactions, and indications for chemotherapy in cancer treatment strategy. Cancer Chemotherapy and Pharmacology is essential reading for pharmacologists and oncologists.

    ", "editor": [ { "familyName": "Chatelut", "givenName": "Etienne", "type": "Person" } ], "id": "sg:journal.1088364", "inLanguage": [ "en" ], "isAccessibleForFree": false, "issn": [ "0344-5704", "1432-0843" ], "license": "Hybrid", "name": "Cancer Chemotherapy and Pharmacology", "productId": [ { "name": "dimensions_id", "type": "PropertyValue", "value": [ "88364" ] }, { "name": "lccn_id", "type": "PropertyValue", "value": [ "sn 80001635" ] }, { "name": "nlm_unique_id", "type": "PropertyValue", "value": [ "7806519" ] }, { "name": "nsd_ids_id", "type": "PropertyValue", "value": [ "340159" ] }, { "name": "era_ids_id", "type": "PropertyValue", "value": [ "14707" ] } ], "publisher": { "name": "Springer Berlin Heidelberg", "type": "Organization" }, "publisherImprint": "Springer", "sameAs": [ "https://app.dimensions.ai/discover/publication?and_facet_source_title=jour.1088364" ], "sdDataset": "journals", "sdDatePublished": "2022-05-10T11:01", "sdLicense": "https://scigraph.springernature.com/explorer/license/", "sdPublisher": { "name": "Springer Nature - SN SciGraph project", "type": "Organization" }, "sdSource": "s3://com-springernature-scigraph/baseset/20220509/entities/gbq_results/journal/journal_0.jsonl", "startYear": "1978", "type": "Periodical", "url": "https://link.springer.com/journal/280" } ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/journal.1088364'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/journal.1088364'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/journal.1088364'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/journal.1088364'


     

    This table displays all metadata directly associated to this object as RDF triples.

    60 TRIPLES      20 PREDICATES      27 URIs      23 LITERALS      10 BLANK NODES

    Subject Predicate Object
    1 sg:journal.1088364 schema:contentRating N0dea630a3946499ab5ad06cb87d221c9
    2 Ne24b97d064364557b8440ced1e6cc448
    3 schema:description <p>Cancer Chemotherapy and Pharmacology addresses a wide range of pharmacologic and oncologic concerns on both experimental and clinical levels. The primary focus of this rapid publication medium is on new anticancer agents, their experimental screening, preclinical toxicology and pharmacology, single and combined drug administration modalities, and clinical phase I, II and III trials. </p><p>The journal publishes results recorded in the following areas: clinical toxicology, pharmacokinetics, pharmacodynamics, drug interactions, and indications for chemotherapy in cancer treatment strategy. Cancer Chemotherapy and Pharmacology is essential reading for pharmacologists and oncologists.</p>
    4 schema:editor Nc865d6b571874290af58a688183bd93e
    5 schema:inLanguage en
    6 schema:isAccessibleForFree false
    7 schema:issn 0344-5704
    8 1432-0843
    9 schema:license Hybrid
    10 schema:name Cancer Chemotherapy and Pharmacology
    11 schema:productId N1a86d7bec52644758c875946ed76275f
    12 N221a586d49ca4e409c39e6fe6323c477
    13 N92a0910b485d4fb9b5c88eb7aa00c952
    14 Ncc36225fae6a47859d8e3f78dbe2ebba
    15 Nfb5ef57058a14bb0a65682ffda652826
    16 schema:publisher N300e13ecd2fe47ce88c6bfee0614cdd4
    17 schema:publisherImprint Springer
    18 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_source_title=jour.1088364
    19 schema:sdDatePublished 2022-05-10T11:01
    20 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    21 schema:sdPublisher N07d3de3611b94fc798b1863b19453c8c
    22 schema:startYear 1978
    23 schema:url https://link.springer.com/journal/280
    24 sgo:license sg:explorer/license/
    25 sgo:sdDataset journals
    26 rdf:type schema:Periodical
    27 N07d3de3611b94fc798b1863b19453c8c schema:name Springer Nature - SN SciGraph project
    28 rdf:type schema:Organization
    29 N0dea630a3946499ab5ad06cb87d221c9 schema:author N51c6db12b12c4d51aae787182eb262e7
    30 schema:ratingValue 0.9259999990463257
    31 rdf:type schema:Rating
    32 N1a86d7bec52644758c875946ed76275f schema:name nsd_ids_id
    33 schema:value 340159
    34 rdf:type schema:PropertyValue
    35 N221a586d49ca4e409c39e6fe6323c477 schema:name era_ids_id
    36 schema:value 14707
    37 rdf:type schema:PropertyValue
    38 N300e13ecd2fe47ce88c6bfee0614cdd4 schema:name Springer Berlin Heidelberg
    39 rdf:type schema:Organization
    40 N450edae396c24f1aaa21a7b71adde6b8 schema:familyName Chatelut
    41 schema:givenName Etienne
    42 rdf:type schema:Person
    43 N51c6db12b12c4d51aae787182eb262e7 rdf:first snip
    44 rdf:rest rdf:nil
    45 N65b37407f7c74b20a4d9d88a47c09c6a rdf:first sjr
    46 rdf:rest rdf:nil
    47 N92a0910b485d4fb9b5c88eb7aa00c952 schema:name lccn_id
    48 schema:value sn 80001635
    49 rdf:type schema:PropertyValue
    50 Nc865d6b571874290af58a688183bd93e rdf:first N450edae396c24f1aaa21a7b71adde6b8
    51 rdf:rest rdf:nil
    52 Ncc36225fae6a47859d8e3f78dbe2ebba schema:name nlm_unique_id
    53 schema:value 7806519
    54 rdf:type schema:PropertyValue
    55 Ne24b97d064364557b8440ced1e6cc448 schema:author N65b37407f7c74b20a4d9d88a47c09c6a
    56 schema:ratingValue 1.1119999885559082
    57 rdf:type schema:Rating
    58 Nfb5ef57058a14bb0a65682ffda652826 schema:name dimensions_id
    59 schema:value 88364
    60 rdf:type schema:PropertyValue
     




    Preview window. Press ESC to close (or click here)


    ...